Cargando…
US Support for a WTO Waiver of COVID-19 Intellectual Property
Autor principal: | Contreras, Jorge L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176658/ https://www.ncbi.nlm.nih.gov/pubmed/34103764 http://dx.doi.org/10.1007/s10272-021-0976-7 |
Ejemplares similares
-
Mixed response to COVID-19 intellectual property waiver
por: Zarocostas, John
Publicado: (2022) -
What next for a COVID-19 intellectual property waiver?
por: Zarocostas, John
Publicado: (2021) -
Time to boost COVID-19 vaccine manufacturing: The need for intellectual property waiver by big pharma
por: Okereke, M., et al.
Publicado: (2021) -
Improving Access to COVID-19 Vaccines: An Analysis of TRIPS Waiver Discourse among WTO Members, Civil Society Organizations, and Pharmaceutical Industry Stakeholders
por: Kohler, Jillian, et al.
Publicado: (2022) -
Ensuring fair distribution of COVID-19 vaccines: is an intellectual waiver the answer?
por: Burki, Talha Khan
Publicado: (2021)